-
Support Care Cancer: Effects of Exercise Rehabilitation on Function ability and Quality of Life of Head and Neck Cancer Patients Undergoing Chemotherapy Radiotherapy
Time of Update: 2020-07-13
Fatigue, reduced function and impaired quality of life are the most common adverse consequences of chemotherapy radiotherapy (CRT) Head and neck cancer (HNC) affects more than half a million people
-
Melanoma cancer vaccine Seviprotimut-L, FDA Fast Track Certification
Time of Update: 2020-07-13
Polynoma Biopharmaceuticals inc announced that the U.S Food and Drug Administration ( FDA ) has granted fast-track designations to its melanoma cancer vaccine, Seviprotimut-L, for complementary tr
-
J Clin Oncol: Health-related quality of life in Patients with Hodgkin's Lymphoma for 5 Years (HRQoL)
Time of Update: 2020-07-13
Health-related quality of life (HRQoL) refers to the determination of subjective health status and individual satisfaction associated with individual life events under the influence of disease, acci
-
Nat Med: New developments: Blood tests can accurately identify different types of brain tumors
Time of Update: 2020-07-13
Recently, researchers have discovered a simple but highly sensitive blood test that accurately diagnose and classify different types of brain tumors, providing patients with more accurate and intr
-
AACR 2020: IL-15 Superagotic SO-C101 shows strong anti-tumor effect
Time of Update: 2020-07-13
At the 2020 American Association for Cancer Research (AACR) online meeting, SOTIO and Cytune Pharma announced IL-15 superagotics SO-C101 as a monotherapy, or in conjunction with PD-1 inhibitors, to
-
Clin Cancer Res: Immunotherapy targeting HPV16/18 produces a strong immune response in HPV-related head and neck cancers
Time of Update: 2020-07-13
About 20% of patients with advanced head and neck squamous cell carcinoma (HNSCCa) have a clinical response to stage death (PD-1) receptor-oriented antibodies New viral antigens, such as HPV16/18's
-
Int J Clin Oncol: 4-day MEA treatment for velvet cancer and high-risk GTN
Time of Update: 2020-07-13
The purpose of this study was to assess the efficacy and toxicity of 4 days of chemotherapy and methotrexate, optoside and linemycin D (MEA) for diagnosis patients with velvet cancer and high-risk
-
Cancer Cell: A Big Discovery! A metabolic enzyme can inhibit the growth and spread of liver cancer cells
Time of Update: 2020-07-13
Liver cancer is very difficult to treat because of the complexity of its causes There is no targeted and effective treatment for liver cancer A new study in the United States has found that an enzym
-
New advances in anti-cancer compounds! Cell 'lava lamp' effect makes cancer drugs more effective
Time of Update: 2020-07-13
Pharmacometabolic kinetics refers to the invivial process of a drug, studying the absorption, distribution, metabolism and excretion of drugs, as well as the laws of blood concentration over time It
-
Support Care Cancer: Multimodal exercise improves the motor response and body composition of head and neck cancer patients who receive chemotherapy
Time of Update: 2020-07-13
Studies have found that many chemotherapy drugs can have multiple side effects and complications in cancer patients, especially in heart vascular diseases The purpose of this study was to explore
-
Inter J Phar: University of South Australia develops new prostate cancer drug with 40 per cent increase in efficacy
Time of Update: 2020-07-13
Introduction: Prostate cancer is one of the highest malignant tumors in older men and is known as the "silent killer" Prostate cancer is the 1st in the United States, with death rates second only to
-
Acta Oncol: Compliance in preventive swallowing training in patients with head and neck cancer undergoing radiotherapy (chemotherapy)
Time of Update: 2020-07-13
In recent years, have been studied to prevent swallowing as a means of limiting the difficulty of swallowing in patients with head and neck cancer However, there is little record of adherence to e
-
AACR 2020: Selaxib reduces the incidence of sorafenib-related hand-foot syndrome in liver cancer patients
Time of Update: 2020-07-13
A study presented at the 2020 annual meeting of the American Association for Cancer Research (AACR) showed that seloxib reduces the incidence of sorafeny-related hand and foot syndrome in patients w
-
FDA Approves Clinical Trial satantis anti-tumor drug IDH1 inhibitor HH2301
Time of Update: 2020-07-13
HH2301, a selective inhibitor of hectic acid dehydrogenase 1 (IDH1) mutants developed jointly by the Shanghai Institute of Drug Research and Hai and Biology, has recently been granted implicit clini
-
AACR 2020: PD-L1 single-resistant Tecentriq combined carplatinand and etoposide to improve SCLC survival rate for small cell lung cancer
Time of Update: 2020-07-13
The latest data from the IMpower133 study, presented at the 2020 American Cancer Research Association (AACR) online meeting, assessed the efficacy and safety of Roche's PD-L1 monoantitic Teriq (atez
-
Summary: Counting the 2020 Single Cell Sequencing Study - Oncology
Time of Update: 2020-07-13
Single-cell sequencing has important applications in the fields of tumor, developmental biology, clinical diagnosis , immunology , microbiology, neuroscience, large-scale cell mapping construction
-
1 case of primary lung slip membrane sarcoma
Time of Update: 2020-07-13
Case male, 45 years old, mainly due to "cough cough ingepsis, sputum with blood for more than 70 days" was admitted to hospital Physical examination: chest symmetry, no deformity, two lungs clear, d
-
Lancet oncol: Lofatini and Pym sabuta-resistant combination treatment for advanced stomach cancer
Time of Update: 2020-07-13
Pymsone is an anti-PD-1 antibody, used in the advanced stage of pD-L1 positive total score of 1 stomach cancer patients tumor remission rate of about 15% Lombardinis is a multikine inhibitor of VE
-
Classic Hodgkin's lymphoma (cHL) new drug! Mercadon Keytruda was reviewed by the FDA as a priority, and the efficacy beats Adcetris!
Time of Update: 2020-07-10
, July 10, 2020 / PRNewswire/ -- The U.S Food and Drug Administration (FDA) has accepted a new supplemental biologics licensing application (sBLA) for anti-PD-1 therapy Keytruda (Corrida, generic n
-
Predicttheidh wild GBM core signal path through MRI imaging histology and second-generation sequencing
Time of Update: 2020-06-26
Glioblastoma (GBM) is a common malignant brain tumor Second-generation sequencing (NGS) enables highly sensitive tumor genomics analysis Ji Eun Park of the Institute of Radiology and Radiology at Ulsa